NEW: A tougher stance against the drug that’s been widely touted by President Trump.
BLOOMBERG.COMHydroxychloroquine Shouldn’t Be Used at All for Covid-19, ISDA Says
上述 ISDA是錯打，，應該是IDSA才對：
Hydroxychloroquine Shouldn’t Be Used at All for Covid, IDSA Says
By
Hospitals should drop using the anti-malarial drug hydroxychloroquine altogether to treat Covid-19 patients, even if it’s in a clinical trial, according to new medical guidelines.
The Infectious Diseases Society of America revised its Covid-19 treatment guidelines Friday, toughening its stance against the use of the anti-malarial drug that’s been widely touted by President Donald Trump as a way to deal with the pandemic.
IDSA now recommends not to use hydroxychloroquine either by itself or along with the antibiotic azithromycin for patients with the coronavirus, even in hospitals. The society previously called for limited use of hydroxychloroquine in trials.
More evidence against the drug touted by Trump.
DAILYMAIL.CO.UK | 作者：DAILY MAIL
Hydroxychloroquine does NOT prevent people from contracting COVID-19, researchers say
羥氯喹可降低COVID-19死亡率的說法，最早法國專家主張。 美國總統大力支持之後，據說美國家庭和醫院大量購入。美國的食藥署FDA給它暫時使用許可。
過兩個月，美國的食藥署FDA等單位說根據"隨機化研究'"，
羥氯喹不能降低COVID-19死亡率，還有其他風險，撤回"暫時使用許可"，禁用。FDA是美國"權威單位"。
然而，還是有人對FDA的"結論"存疑，也有報告說"羥氯喹可降低COVID-19死亡率"。
8月3日晚間，無意間在CNN的新聞報導，看到主持人電訊訪談力主"羥氯喹可降低COVID-19死亡率"的耶魯大學名教授Dr. Harvey Risch (他的論點/論文發表在American Journal of Epidemiology )。
如前述，"大部分專家"同意FDA的說法，可是耶魯大學公共衛生學院(YSPH)公開聲明支持Dr. Harvey Risch的學術自由，主張反對Dr. Harvey Risch者必須循學術正常管道提出說法和證據：
YSPH Statement Regarding Hydroxychloroquine < Yale ...publichealth.yale.edu › news-article5 日前 - Dr. Harvey Risch is a distinguished cancer epidemiologist who has opined on the topic of hydroxychloroquine (HCQ) and COVID-19 out-patient therapy. He has written a review article in the American Journal of Epidemiology ...
這是美國制度的可貴：請拿出證據說服我。雖然Dr. Harvey Risch等是非主流/官方說法(Dr. Harvey Risch說，說，FDA的實驗，從來非隨機化，此次它所實驗的病人，都是送入醫院的病重者(In-patient)，對於未送入醫院的症狀較輕者，羥氯喹可降低COVID-19死亡率)，還是尊重。
***** Hydroxychloroquine lowers COVID-19 death rate, Henry Ford Health study finds
2020年7月6日： 羥氯喹可降低COVID-19死亡率，Henry Ford Health study: Hydroxychloroquine lowers COVID ...
www.detroitnews.com › local › michigan › 2020/07/02
Hydroxychloroquine lowers COVID-19 death rate, Henry Ford Health study finds. Sarah Rahal and Beth LeBlanc, The Detroit News Published 1:10 p.m. ET July 2, 2020 | Updated 6:42 p.m. ET July 2, 2020.
美國買太多，清庫存？
美国5月31日向巴西提供2百万剂羟氯喹。在一份声明中，美方表示，为抗击新冠病毒，美国和巴西站在一起，为此我们想巴西提供2百万剂羟氯喹。U.S. Sends Two Million Hydroxychloroquine Doses to BrazilThe donated doses will be used “to help defend” Brazil’s nurses, doctors and health care professionals, despite a lack of evidence of its effectiveness. Here’s the latest.
沒有留言:
張貼留言